Marshall Wace’s Takeda Pharmaceutical TAK Stock Holding History

Marshall Wace’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Buy	+18,000	New	+$298K	﹤0.01%	2737
2025 Q4	–	Sell	-27,766	Closed	-$406K	–	3474
2025 Q3	$406K	Buy	+27,766	New	+$412K	﹤0.01%	2303
2025 Q2	–	Sell	-45,247	Closed	-$673K	–	3162
2025 Q1	$673K	Sell	45,247 -31,007	-41%	-$434K	﹤0.01%	1946
2024 Q4	$1.01M	Buy	+76,254	New	+$1.05M	﹤0.01%	1732
2021 Q2	–	Sell	-41,904	Closed	-$765K	–	3080
2021 Q1	$765K	Sell	41,904 -43,184	-51%	-$777K	﹤0.01%	1780
2020 Q4	$1.55M	Sell	85,088 -22,940	-21%	-$402K	0.01%	1048
2020 Q3	$1.93M	Sell	108,028 -98,724	-48%	-$1.8M	0.01%	817
2020 Q2	$3.71M	Buy	206,752 +121,664	+143%	+$2.18M	0.03%	572
2020 Q1	$1.29M	Sell	85,088 -106,791	-56%	-$1.94M	0.01%	741
2019 Q4	$3.79M	Sell	191,879 -1,867,849	-91%	-$35.7M	0.03%	622
2019 Q3	$35.4M	Sell	2,059,728 -19,342	-0.9%	-$335K	0.28%	73
2019 Q2	$36.8M	Sell	2,079,070 -885,137	-30%	-$16.1M	0.3%	63
2019 Q1	$60.4M	Buy	+2,964,207	New	+$59.6M	0.57%	21

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Marshall Wace's TAK Position: Q2 2026 in Review

Marshall Wace opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 18,000 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #2737 among its holdings. This is a return to the name: Marshall Wace previously reported a position in TAK as recently as Q3 2025.

Marshall Wace first reported a position in TAK in Q1 2019 and has held it in 13 quarters since. The position peaked at $60.4M in Q1 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Marshall Wace held 18,000 shares of Takeda Pharmaceutical worth $289K as of Q2 2026.
Takeda Pharmaceutical was a new Marshall Wace position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2737 holding.
Marshall Wace first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
Marshall Wace's Takeda Pharmaceutical position peaked at $60.4M in Q1 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.